NCAM1 and stroke disorder: Based on these results and on the efficacy of direct triple gene therapy for stroke we proposed to enhance the therapeutic potential of UCB-MC via simultaneous transduction of UCB-MC with Ad-VEGF, Ad-GDNF, and Ad-NCAM.